Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D He

Showing results (391-400 of 410) with videos related to

Pageof 41
Sort By:
Iscience|January 13, 2021
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infectionsSimone A Thair, Yudong D He, Yehudit Hasin-Brumshtein, et al.
Oncogene|February 16, 2016
Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapiesJ Zhou, J Luo, K Wu, et al.
Toxicologic Pathology|May 16, 2013
Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocritDina A Andrews, Babette M Boren, James R Turk, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|March 20, 2025
[Multicenter study on the efficacy of transoral robotic surgery for malignant tongue base tumors]M Song, C Z Xu, K Xu, et al.
Oncogene|April 23, 2013
The role of DAB2IP in androgen receptor activation during prostate cancer progressionK Wu, J Liu, S-F Tseng, et al.
Toxicologic Pathology|May 16, 2013
Cytokines associated with increased erythropoiesis in Sprague-Dawley rats administered a novel hyperglycosylated analog of recombinant human erythropoietinDina A Andrews, Hisham K Hamadeh, Yudong D He, et al.
Physical Review Letters|July 2, 2016
Precision Measurement of the Radiative β Decay of the Free NeutronM J Bales, R Alarcon, C D Bass, et al.
Clinical Pharmacology and Therapeutics|December 17, 2016
Genomewide Association Study Identifies Novel Genetic Loci That Modify Antiplatelet Effects and Pharmacokinetics of ClopidogrelW-P Zhong, H Wu, J-Y Chen, et al.
Regulatory Toxicology and Pharmacology : RTP|June 27, 2020
Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fractureJames R Turk, Aimee M Deaton, Jun Yin, et al.
Nature|February 2, 2002
Gene expression profiling predicts clinical outcome of breast cancerLaura J van 't Veer, Hongyue Dai, Marc J van de Vijver, et al.
Pageof 41

Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Iscience|January 13, 2021
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infectionsSimone A Thair, Yudong D He, Yehudit Hasin-Brumshtein, et al.
Oncogene|February 16, 2016
Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapiesJ Zhou, J Luo, K Wu, et al.
Toxicologic Pathology|May 16, 2013
Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocritDina A Andrews, Babette M Boren, James R Turk, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|March 20, 2025
[Multicenter study on the efficacy of transoral robotic surgery for malignant tongue base tumors]M Song, C Z Xu, K Xu, et al.
Oncogene|April 23, 2013
The role of DAB2IP in androgen receptor activation during prostate cancer progressionK Wu, J Liu, S-F Tseng, et al.
Toxicologic Pathology|May 16, 2013
Cytokines associated with increased erythropoiesis in Sprague-Dawley rats administered a novel hyperglycosylated analog of recombinant human erythropoietinDina A Andrews, Hisham K Hamadeh, Yudong D He, et al.
Physical Review Letters|July 2, 2016
Precision Measurement of the Radiative β Decay of the Free NeutronM J Bales, R Alarcon, C D Bass, et al.
Clinical Pharmacology and Therapeutics|December 17, 2016
Genomewide Association Study Identifies Novel Genetic Loci That Modify Antiplatelet Effects and Pharmacokinetics of ClopidogrelW-P Zhong, H Wu, J-Y Chen, et al.
Regulatory Toxicology and Pharmacology : RTP|June 27, 2020
Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fractureJames R Turk, Aimee M Deaton, Jun Yin, et al.
Nature|February 2, 2002
Gene expression profiling predicts clinical outcome of breast cancerLaura J van 't Veer, Hongyue Dai, Marc J van de Vijver, et al.
Pageof 41